Uniqueness and coincidensity

by

Coincidensity – a really nice neologism that I first saw in a Tweet by social-business specialist David Cushman: davidcushman: RT @stoweboyd: the right word isn’t serendipity, it’s coincidensity: the likelihood of serendipity jonhusband: @tetradian @davidcushman @stoweboyd … I much enjoy the #neologism coincidensity .. bravo ! From the Tweet, I’d assumed that the term had […]

Competition-against or competition-with?

by

What’s the point of competition, in a business-context? Perhaps more to the point, what is competition in a business-context? And why? Another of those ‘obvious’ question-themes that turn out to be not so obvious at all… And the answers are very important in enterprise-architecture, business-architecture and business-model design: not least because if we get it […]

SCAN – work in progress

by

Yes, I know I’ve gone a bit quiet in the past couple weeks, and no, I haven’t abandoned those ideas about SCAN sensemaking and real-time decision-making and the like. Reality is that those ideas are very much in the ‘work in progress’ stage at the moment, and as yet still quite some way from a […]

Enterprise Architecture Certifications Distilled

by

Year after year I am finding that Enterprise Architecture certifications are becoming more important to architects. Back in 2007, I remember reading an article from Gene Leganza called, “Is EA Certification Important?”. In that article he stated that 65% of…

Link Collection — December 11, 2011

by

  • The Technologies in I.B.M.’s Watson Used for Drug Research – NYTimes.com

    “I.B.M.’s Strategic Intellectual Property Insight Platform. Clearly, the Watson branding team didn’t work on this name.

    But then again, this isn’t for television, where Watson performed. It is for major corporate customers, seeking competitive advantage. The technology, sold as a cloud-based service, is the result of several years of joint development between IBM Research and four companies — AstraZeneca, Bristol-Myers Squibb, DuPont and Pfizer.

    The insight platform uses data mining, natural-language processing and analytics to pore through millions of patent filings and biomedical journals to look for chemical compounds used in drug discovery.”

    tags: ibm watson pharma bigdata

  • Gapingvoid: Flowers vs Elephants

    So true… Click to see cartoon

    tags: gapingvoid

  • Bre Pettis | I Make Things – Bre Pettis Blog – The Cult of Done Manifesto

    Good one—> “#13 Done is the engine of more.”

    tags: productivity done manifesto

  • Monitor: More than just digital quilting | The Economist

    “The maker movement is both a response to and an outgrowth of digital culture, made possible by the convergence of several trends. New tools and electronic components let people integrate the physical and digital worlds simply and cheaply. Online services and design software make it easy to develop and share digital blueprints. And many people who spend all day manipulating bits on computer screens are rediscovering the pleasure of making physical objects and interacting with other enthusiasts in person, rather than online. Currently the preserve of hobbyists, the maker movement’s impact may be felt much farther afield.”

    tags: makerfaire innovation diy

Posted from Diigo. The rest of my favorite links are here.

Related posts:

  1. Link Collection — December 4, 2011
  2. Link Collection — October 23, 2011
  3. Link Collection — October 9, 2011

On Semantic Technologies

by

A conversation with Eddy Vanderlinden Semantic technologies have been some temptation for me for quite a long time. That was mainly due to my growing frustration about the utilisation of data resources both inside corporations and outside, on the Internet. Then all mainstream modelling methods used for analysis or for database design and application development, […]